Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Coronavirus: All FDA Inspections Of Chinese Manufacturing Facilities Come To Screeching Halt
In a late Friday news statement, agency head Stephen Hahn also warned of possible “shortages of critical medical products”
Feb 15 2020
•
By
Shawn M. Schmitt
More from Regulation
More from Policy & Regulation